Portfolio · Screening · Ideas

Know exactly what’s working — and what we own.

The same dual-lens engine behind every call we make. 800+ compounders and 300+ ETFs, each scored on a great business and a market that agrees — plus investment ideas, deep-dive research and our complete live portfolio. Built for people who are here for the ideas.

1’000+ subscribers & growing fast Built by a FINMA-supervised fund manager New snapshot every month
arvy Screening
810 names
Live preview · the full universe, scores & portfolio unlock for subscribers Get full access →

The framework

Good Story & Good Chart®

A great investment needs two things to be true at once — a great business, and a market that agrees. We score every name on both, and only get interested when the two line up.

Lens 01 · the business

Good Story

Businesses with enduring competitive advantages — built to compound over decades, not quarters.

  • A real moat that protects returns
  • High returns on invested capital
  • Exceptional, disciplined management
  • Sustainable organic growth
  • A reasonable free-cash-flow valuation
  • Low leverage — survives the bad years
  • A structural tailwind at its back
×
Lens 02 · the market

Good Chart

Price behaviour reveals what narratives cannot. Great fundamentals mean little if the market disagrees.

  • Price structure — the health of the trend
  • Accumulation vs. distribution
  • Relative strength vs. the market
  • New highs — strength confirming strength
  • Linearity — orderly, not jagged
  • Risk managed when conviction isn’t real

Buy great businesses, don’t overpay, and hold them as long as the trend works in your favour. Think like a long-term investor; act with the risk discipline of a trader.

Story × Chart map

The whole universe, in one picture

Every subsector plotted on two axes — Good Story across, Good Chart up. Bubble size scales to how many names sit inside. The top-right corner is where we live.

Leaders, laggards — at a glance.

Hover any bubble to read the subsector. Click to drill into its constituents. The map turns 800+ names into a single read on where strength is rotating.

Leaders ◺
Strong story and strong tape — our hunting ground.
Chart
Market likes it, fundamentals still catching up.
Story
Great business the market hasn’t rewarded… yet.
Lagging
Where value traps and early-but-wrong ideas cluster.

Sector heatmap

Watch leadership rotate

A great business in a weak sector swims against the tide — three of four stocks follow their sector. Eleven sectors, ranked over time. Red is weaker, green is stronger. The story of the market is right there in the colours.

Weaker Stronger

Johnson & Johnson

JNJ · Healthcare · Pharmaceuticals & MedTech
Watchlist
Drug ManufacturersUnited StatesUSDWide moat
Composite
78.0
Story
79.0
Chart
77.0
Sector rk
#5
Quality
ROIC 5y14.0%
ROCE 5y17.0%
ROE 5y31.0%
Margins
Gross69.1%
Net28.5%
CF28.9%
Growth
Fwd EPS 3y8.6%
Fwd EPS 5y9.6%
Fwd Rev 5y7.0%
Cash & leverage
FCF conv.73.5%
Net debt/EBITDA0.7×
Risk / return
Volatility 5y17.0%
CAGR 5y9.2%
Valuation
Fwd P/E22.0×
P/E18.8×
FCF yield4.0%

No black box. Every number, in the open.

Click any name and the full picture opens up — quality, margins, growth, leverage, risk and valuation, side by side, on one screen.

Challenge your own positions. Pull up something you already hold and see how it scores on both lenses.
Understand every score. The “How it works” manual walks through exactly what feeds Story and Chart.
Compare like for like. Same framework across single stocks and 300+ ETFs.

What it’s for

Not predictions. A way to see.

No price targets, no promises. A tool to generate ideas, pressure-test your own, and always know what’s actually moving.

Generate ideas

Filter 800+ compounders and 300+ ETFs by sector, country, currency or moat — and surface names you’d never have found on a list.

Know what’s running

One glance at the heatmap and the Story × Chart map tells you where strength is — and where it’s rotating away.

Challenge your positions

Pull up what you already own and check it against both lenses. Conviction is better when it’s been tested.

Build a watchlist

Star the names that interest you and follow how their Story and Chart scores evolve over time.

See what changed

Monthly snapshots and score history show you the movers — what climbed, what cooled, and why it matters.

See what we own

Our complete, live portfolio sits right next to the engine that generates it — opportunity set on one side, what we did about it on the other.

The live portfolio

The part subscribers ask for most.

Exactly what we own, what we don’t, and how we adjust as trends evolve — sitting right next to the screening that generates it. The screening shows the opportunity set; the portfolio shows what we actually did about it.

A fresh dated snapshot every month, live in the subscriber area.

Unlock the portfolio →
arvy · live holdingssnapshot · 01.07.26
WMWaste ManagementIndustrials · USA5.9%
LINLindeBasic Materials · IRL5.8%
HEIHeicoIndustrials · USA5.3%
MARMarriott Intl.Consumer Cyclical · USA4.9%
CASYCasey’s GeneralConsumer Cyclical · USA4.6%
BKNGBooking HoldingsConsumer Cyclical · USA4.4%
Full holdings & weights for subscribers Every position, updated monthly

How to get in

Two minutes to full access

No password to remember. Your Substack subscription is your key.

1

Subscribe

Become a paid subscriber on Substack — monthly, or annually at 20% off.

2

Enter your email

Go to screening.arvy.ch and enter the exact email Substack has on file.

3

Open your link

A confirmation email lands in your inbox. The link stays valid for a month — request a fresh one anytime.

FAQ

Good questions

What do I actually get?
Full access to the screening — 800+ scored compounders, the 300+ ETF universe, the Sector Heatmap, the Story × Chart map, the “How it works” manual — and our complete live portfolio, updated with a dated snapshot every month.
How do I get access once I subscribe?
Go to screening.arvy.ch and enter the exact email address Substack has on file. You’ll receive a confirmation email with your access link — valid for a month, and you can request a fresh one anytime you’re a paid member.
Is this investment advice?
No. The screening is a research tool and the portfolio reflects arvy’s own positioning — it’s built to help you generate and pressure-test ideas, not to tell you what to buy. It makes no return promises.
Do you cover ETFs too?
Yes — an entire universe of 300+ ETFs, scored on the same Good Story & Good Chart framework as single stocks. Toggle between Stocks and ETFs and the whole engine re-points, so you can own the basket when you’d rather not pick the single winner.
What does it cost?
It’s a paid Substack subscription — monthly, or annually at 20% off. See current pricing on Substack →

Portfolio · Screening · Ideas

The upgrade that pays
for itself.

Full access to the screening, the ETF universe, the heatmap, the map — and the live arvy portfolio. For everyone who’s here for the ideas.

Rather have it managed for you? Meet the arvy app & equity fund →

The screening is a research tool, not investment advice. Holdings shown reflect arvy’s positioning and may change. Figures shown are illustrative of the tool and may not reflect current data. Past performance is not a reliable indicator of future results. arvy AG is authorised by FINMA as a manager of collective assets under CISA Art. 24.

Portfolio · Screening · Ideas800+ stocks · 300+ ETFs · live portfolio
Subscribe → Log in